News
[212 Pb]VMT-α-NET therapy in somatostatin receptor 2 (SSTR2) expressing neuroendocrine tumors (NETs): Dose-limiting toxicity (DLT) observation participants after 1 year follow-up and preliminary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback